4 insider filings
Tao Fu, insider filing for ATTO (amended)
Show all 4
- 4/AInsider filing for ATTO (amended)
- 4/AInsider filing for ATTO (amended)
- 3/ANew insider at ATTO (amended)
- 3/ANew insider at ATTO (amended)
Tao Fu, reporting
ATTO
Attovia Therapeutics, Inc. SEC filings
Every EDGAR filing for Attovia Therapeutics, Inc. (ATTO), newest first, with AI summaries and stories.
- Ticker
- ATTO
- CIK
- 2058707
- Latest filing
- Oct 8
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4/AAttovia Therapeutics, Inc.ATTOLIVE NOTABLE10-QAttovia Therapeutics, Inc.ATTOLIVE ROUTINE8-KAttovia Therapeutics, Inc.ATTOLIVE ROUTINE144Attovia Therapeutics, Inc.ATTOLIVE GOLDMAN SACHS GROUP INC, planned sale of ATTO shares
GOLDMAN SACHS GROUP INC, reporting
ROUTINE4/AAttovia Therapeutics, Inc.ATTOLIVE 2 insider filings
Colin Walsh, insider filing for ATTO (amended)
Show all 2
- 4/AInsider filing for ATTO (amended)
- 4/AInsider filing for ATTO (amended)
Colin Walsh, reporting
ROUTINE4Attovia Therapeutics, Inc.ATTOLIVE 2 insider filings
Colin Walsh, insider filing for ATTO
Show all 2
- 4Insider filing for ATTO
- 4Insider filing for ATTO
Colin Walsh, reporting
ROUTINESCHEDULE 13GAttovia Therapeutics, Inc.ATTOLIVE Ownership stake disclosure by Deep Track Capital, LP
Deep Track Capital, LP, filed by
NOTABLESCHEDULE 13DAttovia Therapeutics, Inc.ATTOLIVE Ownership stake disclosure by Frazier Life Sciences Public Fund, L.P.
Frazier Life Sciences Public Fund, L.P., filed by
ROUTINE4Attovia Therapeutics, Inc.ATTOLIVE 2 insider filings
David Kroin, insider filing for ATTO
Show all 2
- 4Insider filing for ATTO
- 4Insider filing for ATTO
David Kroin, reporting · Deep Track Capital, LP, reporting · +1 more
ROUTINE4Attovia Therapeutics, Inc.ATTOLIVE Redmile Group, LLC, insider filing for ATTO
Redmile Group, LLC, reporting · Jeremy Green, reporting · +1 more
ROUTINE4Attovia Therapeutics, Inc.ATTOLIVE Sanofi, insider filing for ATTO
Sanofi, reporting
ROUTINE4Attovia Therapeutics, Inc.ATTOLIVE 8 insider filings
FHMLS XI, L.P., insider filing for ATTO
Show all 8
- 4Insider filing for ATTO
- 4Insider filing for ATTO
- 4Insider filing for ATTO
- 4Insider filing for ATTO
- 4Insider filing for ATTO
- 4Insider filing for ATTO
- 4Insider filing for ATTO
- 4Insider filing for ATTO
FHMLS XI, L.P., reporting · Frazier Life Sciences XI, L.P., reporting · +1 more
ROUTINE8-KAttovia Therapeutics, Inc.ATTOLIVE ROUTINE3Attovia Therapeutics, Inc.ATTOLIVE Alamar HoldCo, LLC, new insider at ATTO
Alamar HoldCo, LLC, reporting
ROUTINE3Attovia Therapeutics, Inc.ATTOLIVE Colin Walsh, new insider at ATTO
Colin Walsh, reporting
ROUTINE424B4Attovia Therapeutics, Inc.ATTOLIVE ROUTINEEFFECTAttovia Therapeutics, Inc.ATTOLIVE ROUTINE3Attovia Therapeutics, Inc.ATTOLIVE 16 insider filings
David Kroin, new insider at ATTO
Show all 16
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
- 3New insider at ATTO
David Kroin, reporting · Deep Track Capital, LP, reporting · +1 more
ROUTINE3Attovia Therapeutics, Inc.ATTOLIVE Sanofi, reporting
ROUTINECERTAttovia Therapeutics, Inc.ATTOLIVE ROUTINES-1/AAttovia Therapeutics, Inc.ATTOLIVE ROUTINE8-A12BAttovia Therapeutics, Inc.ATTOLIVE